Melanoma Stage Iv clinical trials

Explore recruiting melanoma stage iv clinical trials.

Recruiting melanoma stage iv studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Melanoma Stage Iv trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase-2 clinical trial of regorafenib in patients with pretreated advanced melanoma

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

CRISPR-TIL for metastatic melanoma

Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

ADP-TILIL7

Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy with Nivolumab + Relatlimab Fixed-dose Combination versus Nivolumab Monotherapy after Complete Resection of Stage III-IV Melanoma

Czechia, Denmark, Belgium, Finland, Germany, Italy +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

CRISPR-TIL for metastatic melanoma

Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Stage III and Stage IV Melanoma in the Adjuvant Setting

Italy, Germany, Netherlands, France, Spain, Croatia +2 more

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Melanoma Stage Iv trials by city

Melanoma Stage Iv in Toronto Melanoma Stage Iv in Vancouver Melanoma Stage Iv in Montreal Melanoma Stage Iv in Calgary Melanoma Stage Iv in Edmonton Melanoma Stage Iv in Ottawa Melanoma Stage Iv in Winnipeg Melanoma Stage Iv in Quebec City Melanoma Stage Iv in Hamilton Melanoma Stage Iv in Kitchener Melanoma Stage Iv in London Melanoma Stage Iv in Halifax Melanoma Stage Iv in New York Melanoma Stage Iv in Los Angeles Melanoma Stage Iv in Chicago Melanoma Stage Iv in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease